The purpose of this study is to develop a clinical dataset of sarcoidosis patients with a diagnosis of cancer who are categorized by date of birth, sex, race/ethnicity, clinical information, laboratory and imaging information, time of sarcoidosis onset, cancer type and treatment, time of cancer diagnosis, stage and grade.
Study Type
OBSERVATIONAL
Enrollment
171
University of Miami, Miller School of Medicine
Miami, Florida, United States
Pathology Proven Sarcoidosis In Patients with Cancer
Number of Participants With Sarcoidosis Events as Assessed by Positive Granulomatous Reaction in the Biopsies of Lung, Mediastinal Lymph Nodes, or Other Organs After Cancer Diagnosis.
Time frame: up to 10 years
Cancer Cytogenetics and Sarcoidosis
Number of Participants With Sarcoidosis Events as Assessed by Cancer Cytogenetic Profiles of Cancer.
Time frame: up to 10 years
Treatment Requirement of Sarcoidosis
Number of Participants With Sarcoidosis Events as Assessed by Requirement of Treatment with Steroid or Other Anti-Sarcoid Medications in Patients with Cancer.
Time frame: up to 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.